Bleeding Disorders (incl. Hemophilia, Von Willebrand Disease) Newsletter
-
Media and mental health, hemophilia approval, July FDA recap, and more
04 Aug 2025 16:29 GMT
… 12 years and older with hemophilia A or B without inhibitors … ) by 86% in hemophilia A and 79% in hemophilia B patients compared …
-
FDA Approves Concizumab as Daily Prophylaxis for Hemophilia A and B
02 Aug 2025 00:22 GMT
… in Haemophilia, community pharmacy involvement in dispensing hemophilia treatment … works without inhibitors for hemophilia A or B. … of Washington Center for Bleeding Disorders in Seattle, Washington, … Body if You Have Haemophilia Without Inhibitors (explorer8). …
-
FDA Expands Approval of Concizumab-mtci to Include Hemophilia A, B Without Inhibitor Use
01 Aug 2025 17:53 GMT
… bleeding episodes in a larger hemophilia population. The approval, … provide to patients with hemophilia, both with and without … the Washington Center for Bleeding Disorders, said in the news … in people with haemophilia A or haemophilia B without inhibitors …
-
Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients
01 Aug 2025 17:20 GMT
… with inhibitors.
Currently, many hemophilia A or B treatments … Seeks Label Expansion For Hemophilia Drug After Promising Data
By … treatment choice for patients with hemophilia with inhibitors, and now … bleeds.
All children with hemophilia A with inhibitors (n …
-
NHS broadens access to haemophilia A drug Hemlibra
01 Aug 2025 11:10 GMT
… only treatment currently available for haemophilia A via the NHS … about 100 people with moderate haemophilia in England will be … emicizumab means more people with haemophilia A will have more … for NHS commissioning for severe haemophilia A with inhibitors in …
-
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors
01 Aug 2025 10:51 GMT
… 12 years and older with hemophilia A or B (HA…
-
Expanded Concizumab Approval Offers Subcutaneous Prophylaxis for Hemophilia Without Inhibitors
01 Aug 2025 01:14 GMT
… , Scientific Director, Washington Center for Bleeding Disorders, Seattle, WA, said in a … for Alhemo® for those with hemophilia with inhibitors—an especially significant … development in hemophilia B where challenges still exist …
-
FDA approves concizumab-mtci for hemophilia A/B without inhibitors in patients 12 years and older
01 Aug 2025 00:46 GMT
… —an especially significant development in hemophilia B where challenges still exist … 35+ year legacy in rare bleeding disorders to continue to help address … for Bleeding Disorders, Seattle, Washington. “With today’s approval of Alhemo® for hemophilia …
-
Maharashtra Orders 6,130 Vials Of Life-Saving AHF Worth ₹4.49 Crore For Hemophilia Patients
31 Jul 2025 19:09 GMT
… a major relief for hemophilia patients in Maharashtra, the … Kotecha, Secretary of the Hemophilia Society (Mumbai Chapter), said … medical emergency. The Hemophilia Society had repeatedly raised … Mumbai.
What is Hemophilia?
Hemophilia is a rare genetic …
-
Phase 2 PRIMUS-AD Trial to Test Anti-Amyloid Oligomer PRI-002 in Alzheimer Disease
03 Aug 2025 17:12 GMT
… , significant hepatic or renal impairment, bleeding disorders, or infections such as HIV …
About
© 1995-2025